Enabling Precision Medicine in Oncology, CNS & NASH to Power Advanced, Affordable Diagnostics for All
April 26-27, 2023 | London, UK
NEW VENUE ANNOUNCED!
Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance & Commercialisation Path to Improve Clinical Decision Making & Patient Outcomes
Welcome to the 13th World Clinical Biomarker & CDx Europe Summit 2023!
The 13th Clinical Biomarkers & CDx Europe 2023 returns as the premier European forum for end-to-end discussions, actionable insights and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress towards commercialisation.
With two dedicated tracks on Biomarker Development and Drug-Dx Development & Commercialisation, this summit will be your ultimate guide to:
Understand European Biomarkers & CDx Development advancements in multiple disease areas in oncology and non-oncology indications
Discuss emerging functional assays and software technologies to advance and accelerate clinical and research programs aimed at personalising care for patients
Stay up to date with European specific regulatory, commercialisation and market access challenges and processes to successfully create your end-to-end biomarker & CDx strategy
Join forces to define a better framework for reimbursement of biomarkers that enable an equitable access to them for patients
Whether working in Oncology, NASH, Neuroscience, Inflammatory or cardiovascular diseases, come and join 250+ Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics Directors, Heads and VPs together with biomarker and CDx solution providers, regulatory experts and notified bodies for a well-rounded, all stakeholders included learning and networking experience that you can’t afford to miss out.
Attendence is Free for Biotech and Pharma
Snapshot of Our 2023 Expert Speaker Faculty:
Vice President - Translational Oncology
Global Director, IVD Focus Team & Strategic Account Manager
IVD Business Line Manager & Senior Specialist (CDx)
Regeneron Pharmaceuticals Inc
Vice President Translational Medicine
Director - Precision Medicine Policy
Chief Scientific Officer
Deputy Director, Innovative Devices
Medicines & Healthcare Products Regulatory Agency (MHRA)